President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget
In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online
News Analysis: IOM Report A Case Study In Communications Disaster
NCI Programs: Coleman To Lead NCI’s New Radiation Oncology Program
Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification
In Brief: Online Genetics Glossary; ORI Misconduct Finding
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - The Galleri MCD vote: What FDA asked its advisors to ignore
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
